A new approach of using platelet-rich autologous plasma to increase the ovarian reservoir in a Syrian patient with ovarian insufficiency: A case report
- PMID: 34976384
- PMCID: PMC8683667
- DOI: 10.1016/j.amsu.2021.103149
A new approach of using platelet-rich autologous plasma to increase the ovarian reservoir in a Syrian patient with ovarian insufficiency: A case report
Abstract
Introduction: The prevalence of Primary ovarian insufficiency (POI) is estimated to be 1-2%, resulting from many causes, including, iatrogenic causes which are becoming more common.There is no precise treatment to restore fertility in POI patients. However, new treatments -such as ovarian rejuvenation using platelet-rich autologous plasma (PRP)- are being tested and have shown promising results. We report using a new PRP injection protocol to manage a Syrian patient with ovarian insufficiency.
Case presentation: A 35-year-old woman with five years of primary infertility presented with decreased anti-mullerian hormone (AMH) after she underwent a laparoscopy one year ago. Where the AMH dropped from 1.07 to 0.39 ng/mL after it. She underwent an ovarian rejuvenation using PRP. Half mL of PRP was injected into every ovary, 2 mL were injected into the cervix, 7 mL intra-uterus, and 7 mL were injected intramuscularly to the patient's legs. Fifteen days following the operation, the patient's new AMH level was 0.94 ng/mL. The patient was placed on ovarian stimulation, and five days later the ultrasonography showed the development of six follicles in each ovary.
Discussion: Managing POI using ovarian rejuvenation is the best alternative treatment; When the donor eggs programs are not acceptable. The use of PRP in ovarian rejuvenation has been reported to be effective.
Conclusion: The use of PRP was beneficial in restoring fertility in a Syrian patient with ovarian insufficiency. Furthermore, the new PRP injection protocol was successful. However, more studies are needed to confirm this result.
Keywords: Diminished ovarian reserve; Iatrogenic; Infertility; Ovarian insufficiency; Platelet-rich plasma; Premature ovarian failure; Primary ovarian insufficiency; Treatment.
© 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation.Reprod Biol Endocrinol. 2020 Aug 5;18(1):78. doi: 10.1186/s12958-020-00638-4. Reprod Biol Endocrinol. 2020. PMID: 32758249 Free PMC article.
-
Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.Reprod Sci. 2021 Jul;28(7):2050-2059. doi: 10.1007/s43032-021-00483-9. Epub 2021 Mar 8. Reprod Sci. 2021. PMID: 33683669
-
Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report.Front Endocrinol (Lausanne). 2020 Feb 19;11:50. doi: 10.3389/fendo.2020.00050. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32140135 Free PMC article.
-
A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency.Cureus. 2020 Dec 12;12(12):e12037. doi: 10.7759/cureus.12037. Cureus. 2020. PMID: 33457137 Free PMC article. Review.
-
The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency.Curr Opin Obstet Gynecol. 2022 Jun 1;34(3):133-137. doi: 10.1097/GCO.0000000000000784. Curr Opin Obstet Gynecol. 2022. PMID: 35645011 Review.
Cited by
-
Effects of Platelet-Rich Plasma on the Oxymetholone-Induced Testicular Toxicity.Diseases. 2023 Jun 9;11(2):84. doi: 10.3390/diseases11020084. Diseases. 2023. PMID: 37366872 Free PMC article.
-
Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.J Ovarian Res. 2024 May 17;17(1):104. doi: 10.1186/s13048-024-01423-2. J Ovarian Res. 2024. PMID: 38760869 Free PMC article.
-
Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement.J Clin Med. 2024 Aug 5;13(15):4571. doi: 10.3390/jcm13154571. J Clin Med. 2024. PMID: 39124838 Free PMC article. Review.
-
Biological therapies for premature ovarian insufficiency: what is the evidence?Front Reprod Health. 2023 Sep 7;5:1194575. doi: 10.3389/frph.2023.1194575. eCollection 2023. Front Reprod Health. 2023. PMID: 37744287 Free PMC article. Review.
-
Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence.Reprod Sci. 2023 Dec;30(12):3428-3442. doi: 10.1007/s43032-023-01300-1. Epub 2023 Jul 17. Reprod Sci. 2023. PMID: 37460850 Review.
References
-
- National cancer institute at the national institutes of health. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primar...
Publication types
LinkOut - more resources
Full Text Sources
Research Materials